ULTHERA SYSTEM
Report
- Report Number
- 3006560326-2024-00008
- Event Type
- Injury
- Date Received
- November 1, 2024
- Date of Event
- October 5, 2024
- Report Date
- November 1, 2024
- Manufacturer
- MERZ NORTH AMERICA, INC.
- Product Code
- OHV
- UDI-DI
- 00840763100902
- PMA / PMN Number
- K180623
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- NURSE
- Health Professional
- Yes
Narratives
NO MALFUNCTIONS OF AN ULTHERA DEVICE DURING TREATMENT WERE ALLEGED RELATED TO THIS REPORTED EVENT. ATTEMPTS TO OBTAIN A SUPPORT LOG AND ADDITIONAL INFORMATION RELATED TO THE DEVICES USED DURING THIS TREATMENT WERE MADE ON 11-OCT-2024, 16-OCT-2024, 21-OCT-2024, 25-OCT-2024, AND 29-OCT-2024. NO ADDITIONAL INFORMATION WAS PROVIDED. FOUR DEVICES WERE REPORTED TO HAVE BEEN USED DURING TREATMENT: ULTHERA UC-1 CONTROL UNIT (SERIAL NUMBER: (B)(6)), UH-2 HANDPIECE (SERIAL NUMBER: (B)(6)), AND TRANSDUCERS (SERIAL NUMBERS: (B)(6)). AN EVALUATION OF THE ORIGINAL DEVICE HISTORY RECORDS (DHRS) FOR ULTHERA UC-1 CONTROL UNIT (SERIAL NUMBER: (B)(6)) AND UH-2 HANDPIECE (SERIAL NUMBER: (B)(6)) REVEALED NO DEVIATIONS, REWORK, OR NON-CONFORMANCES WERE ASSOCIATED WITH THE MANUFACTURE OF THESE DEVICES. ALL REQUIRED TESTING PASSED PRIOR TO DISTRIBUTION FOR EACH DEVICE. A REVIEW OF SERVICE HISTORY RECORDS (SHRS) FOR THE CONTROL UNIT AND HANDPIECE FOUND NEITHER DEVICE HAS BEEN SERVICED SINCE DISTRIBUTION. AN EVALUATION OF THE DHRS FOR THE REPORTED TRANSDUCERS COULD NOT BE PERFORMED AS THEY ARE NOT KNOWN ULTHERA DEVICE SERIAL NUMBERS. ATTEMPTS TO OBTAIN CLARIFICATION OF THE ULTHERA TRANSDUCER SERIAL NUMBERS WERE NOT SUCCESSFUL. THE PATIENT INVESTIGATION FOUND THERE ARE NOT ENOUGH DETAILS TO CONFIRM WHETHER A MERZ/ULTHERA DEVICE MALFUNCTIONED DURING TREATMENT. AS THE SERIAL NUMBERS PROVIDED FOR THE TRANSDUCERS USED DURING THIS TREATMENT ARE NOT KNOWN ULTHERA SERIAL NUMBERS, IT IS UNKNOWN IF THE TRANSDUCER SERIAL NUMBERS WERE INCORRECTLY PROVIDED OR IF THE TRANSDUCERS USED WERE NOT AUTHENTIC ULTHERA DEVICES. IT IS UNCONFIRMED WHETHER A MERZ/ULTHERA DEVICE CAUSED OR CONTRIBUTED TO THE ALLEGED PATIENT INJURY. REPORTEDLY, THE BURN WAS ASSESSED TO BE A THIRD-DEGREE BURN. NO INFORMATION ON CORRECTIVE TREATMENT WAS PROVIDED. ADDITIONALLY, THE INFORMATION IN THIS CASE IS QUITE SPARSE AND NO FURTHER INFORMATION ON EVENT DETAILS OR UNDERLYING CONDITIONS WERE PROVIDED. CAUSALITY IS ASSESSED AS POSSIBLY RELATED TO THE TREATMENT WITH ULTHERA SYSTEM DUE TO COMPATIBLE LOCAL AND TEMPORAL RELATIONSHIP. THIS CASE IS CONSERVATIVELY CONSIDERED AS SERIOUS WITH THE SERIOUS EVENT APPLICATION SITE BURN BECAUSE POTENTIAL MEDICAL INTERVENTION IS DEEMED NECESSARY TO PREVENT A PERMANENT DAMAGE. NO ADDITIONAL INVESTIGATION OR CORRECTIVE ACTIONS ARE WARRANTED FOR THIS COMPLAINT. FURTHERMORE, THIS COMPLAINT IS NOT SUBJECT TO ANY CURRENT FIELD CORRECTIVE ACTION (FCA). ULTHERA WILL MONITOR COMPLAINT DATA ACCORDING TO CURRENT STATISTICAL TREND ANALYSIS PROCEDURES. ANY STATISTICALLY VALID SIGNALS OR TRENDS WILL BE ESCALATED TO MRB VIA ISSUE REVIEW FOR CAPA CONSIDERATION. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. WHEN ADDITIONAL INFORMATION IS RECEIVED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.
ON 11-OCT-2024, ULTHERA RECEIVED INFORMATION FROM A BRAZILIAN AFFILIATE VIA EMAIL REGARDING A POTENTIAL ULTHERA ADVERSE EVENT. ACCORDING TO THE REPORT, ULTHERAPY WAS PERFORMED ON A MALE PATIENT, DEMOGRAPHICS UNKNOWN, TO THE MIDDLE THIRD OF THE FACE ON (B)(6) 2024. THE FOLLOWING DAY, (B)(6) 2024, THE PATIENT ALLEGEDLY EXPERIENCED A ¿GRADE 3¿ BURN ON THE LOWER THIRD OF THE LEFT SIDE OF THE FACE. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION RELATED TO THE PATIENT¿S TREATMENT AND PATIENT SYMPTOM RESOLUTION WERE MADE ON (B)(6) 2024. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 630833 | ULTHERA SYSTEM | FOCUSED ULTRASOUND FOR TISSUE HEAT OR MECHANICAL CELLULAR DISRUPTION | OHV | MERZ NORTH AMERICA, INC. | UC-1 | 00840763100902 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Male | Required Intervention |